Deferred Revenue (Tables)

9 Months Ended

Sep. 30, 2018

Revenue Recognition [Abstract]

Schedule of Deferred Revenue Activity

The following is a summary of the Company’s deferred revenue activity as of September 30, 2018:

(in thousands)	BED				Other Opioid Treatments				Grants			Total
Balance as of December 31, 2017		$	895			$	1,600		$	—		$	2,495
Converted to Equity		—				(1,600		)	—			(1,600		)
Increase to deferred revenue		—				—			500			500
Recognized as revenue		(170		)		—			(163		)	(333		)
Balance as of September 30, 2018		$	725			$	—		$	337		$	1,062

Deferred Revenue, by Arrangement

The remaining $402 thousand was recorded as a long-term liability as of September 30, 2018, as detailed in the following table: 

(in thousands)	BED			Other Opioid Treatments			Grants		Total
Current portion		$	323		$	—	$	337	$	660
Long-term portion		402			—		—		402
Total		$	725		$	—	$	337	$	1,062